SSY Group (HK:2005) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SSY Group Limited has successfully gained approval from China’s National Medical Products Administration for its Paracetamol Tablets, adding a new 0.5g specification to its lineup. Both the 0.3g and 0.5g versions have passed the Consistency Evaluation of the Quality and Efficacy of Generic Drugs, marking significant progress in the company’s product development efforts. This advancement could potentially enhance SSY Group’s position in the pharmaceutical market.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.